It appears as though FDA have approved ind.
Address states that -
"The US clinical trial will begin as soon as possible after final results are known for the Queensland dose escalation study for the smaller implant. Present estimates are that these results will be available in December"
I would have thought the go ahead would have been worthy of a market sensitive announcement, what about you guys?
Despite what appear to be slightly further delays nothing much has changed, Melanotan will reach the market and the share price will no doubt improve.
They are still quoting a $7 bil annual market potential!!!
Just a little patience required imho.
As for the patent issue, well I'm confident the company directors are working for us, not against.
cheers, stainless
It appears as though FDA have approved ind.Address states that -...
-
- There are more pages in this discussion • 2 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add CUV (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$15.37 |
Change
0.130(0.85%) |
Mkt cap ! $770.0M | |||
| Open | High | Low | Value | Volume |
| $15.36 | $15.54 | $15.18 | $1.274M | 82.63K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 237 | $15.31 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $15.50 | 282 | 2 |
View Market Depth
| Last trade - 16.10pm 28/06/2024 (20 minute delay) ? |
| CUV (ASX) Chart |